2,145
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Cytotoxic and nitric oxide inhibitory activities of methanol extracts of Garcinia species

, , , , , & show all
Pages 1019-1026 | Received 11 May 2008, Accepted 18 Jan 2009, Published online: 19 Oct 2009

Abstract

The methanol extracts of 32 plant parts of 19 species of the genus Garcinia (Guttiferae) were collected from rainforests of the Malaysian Peninsula and the island of Sumatra, Indonesia, for evaluation of their in vitro cytotoxic and nitric oxide inhibitory activities. An end-point MTT cell viability assay was used to determine the 50% inhibitory concentration (IC50) of the extracts in three human tumor cell lines representing tumors of the breast (MCF-7), lung (NCI-H460) and prostate (DU-145). Griess assay was performed to assess the nitric oxide (NO) inhibitory activity. Of the 32 extracts, 27 showed cytotoxic activity in at least one of the three tumor cell lines used in this study. Four extracts, Garcinia opaca King (fruit), Garcinia maingayi Hook.f. (stem), Garcinia penangiana Pierre (leaf) and Garcinia urophylla Scortech.ex King (leaf) extracts showed the most potent and selective cytotoxic activity against MCF-7 cells (IC50 3-8 μg/mL). The extracts from Garcinia cowa Roxb. (stem), Garcinia bancana Miq. (stem) and Garcinia malaccensis Hook.f. (leaf) showed moderate activity and selectivity towards non-small lung tumor cells. The extracts from Garcinia bancana (stem), Garcinia malaccensis (stem), Garcinia prainiana King (leaf), Garcinia rostrata Hassk.ex Hook.f. (stem and leaf), Garcinia cowa (stem) and Garcinia nervosa Miq. (leaf) exhibited inhibition against NO production without affecting the viability of LPS and IFN-γ-induced RAW 264.7 macrophage cells. Among these, the most promising extracts were G. bancana (stem) and G. malaccensis (stem), as they showed the highest selectivity indices (> 50) for NO inhibition. In conclusion, these data provide evidence that some of the Garcinia species could potentially contain potent and selective cytotoxic and anti-inflammatory agents.

Introduction

Garcinia (Guttiferae) species are commonly found in the lowland areas of the rainforests. They consist of about 400 species within the paleotropical regions concentrated mainly in south-east Asia, and secondarily in India and west Africa (CitationCorner, 1988). Garcinia species are typically small to medium dioecious evergreen fruit trees, although some occur as shrubs, and usually produce hard timber. Some traditional uses and medicinal properties of this species were documented by CitationBurkill (1966). A list of the traditional uses of these plants as well as their local names is shown in .

Table 1. List of Garcinia species and their traditional uses in Malaysia and West Sumatra, Indonesia.

In relation to the phytochemical studies, this genus is commonly reported to contain xanthones, benzophenones, triterpenes, biflavonoids and benzoquinone (CitationWaterman & Hussain, 1983; CitationPeres et al., 2000; CitationSadaquat et al., 2000; CitationKenji et al., 2003; CitationRukachaisirikul et al., 2008). The biological activities of the isolated compounds include anti-inflammatory (CitationNakatani et al., 2002), anti-HIV (CitationLin et al., 1997) and antibacterial (CitationPermana et al., 2001; CitationRukachaisirikul et al., 2003, Citation2005). Xanthones are especially noted as potential anticancer agents (CitationThoison et al., 2000; CitationMatsumoto et al., 2003a; CitationChiang et al., 2003; Ito et al., Citation2003a).

The phytochemistry of the popular Garcinia species, such as Garcinia mangostana Linn. and Garcinia kola Heckel, has been extensively investigated. However, only a few studies involving other less popular species such as those listed in have been conducted. These include Garcinia nigrolineata Planch.ex T. Andres. (CitationRukachaisirikul et al., 2003), Garcinia bancana Miq. (CitationRukachaisirikul et al., 2005), Garcinia cowa Roxb. (CitationLikhitwitayawuid et al., 1998) and Garcinia parvifolia Miq. (CitationXu et al., 1998; CitationRukachaisirikul et al., 2008). We have recently reported the cytotoxic constituents from Garcinia penangiana Pierre (CitationJabit et al., 2007), Garcinia urophylla Scortech.ex King (CitationKhalid et al., 2007) and Garcinia cantleyana T.C. Whitmore (CitationShadid et al., 2007). A number of new prenylated and caged prenylated xanthones have been found to exhibit strong cytotoxic activities and thus present good potential as new cytotoxic agents.

Inflammation is a pathophysiological process mediated by a variety of signaling molecules produced mainly by leukocytes, macrophages and plasma cells. Macrophages play a crucial role in the generation of the pro-inflammatory molecule nitric oxide (NO). NO synthesized by the enzyme inducible nitric oxide synthase (iNOS) has been reported as a mediator of acute and chronic inflammation (CitationHeras et al., 2001). Studies have shown that macrophages, upon stimulation with bacterial lipopolysaccharide (LPS), express iNOS to produce large amount of NO. iNOS is one of the essential components of the inflammatory response and is involved in the pathogenesis of several inflammatory diseases such as asthma and rheumatoid arthritis. In this study, using Griess assay to measure the level of NO produced by activated murine RAW 264.7 macrophage cells, plant extracts were tested for their anti-inflammatory activity. We also report the cytotoxic potential of plant extracts against three human tumor cell lines of the breast, lung and prostate, with the aim of identifying potent and tumor selective plant extracts. The main intention of this paper is to promote more research to be undertaken to isolate and identify bioactive compounds from the less popular Garcinia species that might be responsible for anticancer and anti-inflammatory activities.

Materials and methods

Plant materials

All Garcinia species were collected from the Peninsula Malaysia except Garcinia cowa and Garcinia merguensis Wight which were collected from West Sumatra, Indonesia in July toNovember 2001-2003. They were identified by Shamsul Khamis of the Institute of Bioscience, Universiti Putra Malaysia, and Rusdi Tamin of Andalas University, West Sumatra, Indonesia. The samples were deposited in the Herbarium of the Institute of Bioscience, Universiti Putra Malaysia and ANDA Herbarium, Andalas University ().

Table 2. Different plant parts of Garcinia species used for bioassays, their weights and percentage yields of the methanol extracts.

Preparation of crude extracts

About 100 g each of the sample (leaf, stem, bark and fruit) was ground to powder and macerated with methanol for three days and filtered. The filtrate was evaporated under reduced pressure at 40°C to obtain a crude extract. The procedure was repeated three times for each sample.

Cell culture

Three types of human tumor cell lines, DU-145 (prostate), MCF-7 (breast) and NCI-H460 (non-small cell lung) were used in the cytotoxic studies. RAW 264.7 (murine monocytic macrophage) cells were used in the Griess assay. The cells were purchased from the American Type Culture Collection (Manassas, VA, USA). The cancer cells were cultured in RPMI-1640 medium (Life Technologies, Paisley, Scotland) with 10% v/v fetal calf serum (PAA Laboratories, Linz, Austria), 100 IU/mL penicillin and 100 μg/mL streptomycin (Life Technologies). The RAW 264.7 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) (Life Technologies) with phenol red containing HEPES, l-glutamine supplemented with 10% fetal bovine serum (FBS) and 1% antibiotic/antimycotic solution (Gibco/BRL). All cells were grown in a humidified environment containing 5% CO2 at 37°C. The cells were maintained in 25 cm2 flask (TPP, Trasadingen, Switzerland) using 10 mL of medium.

In vitro test for cytotoxic activity - 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) cell viability assay

Subconfluent DU-145, MCF-7 and NCI-H460 cells were trypsinized, detached and made into suspensions of single cells before seeding them into 96-well microculture plates. The cell concentrations were set at 3,000, 4,000, and 2,500 cells/well, respectively. Crude extracts were tested at 0.1, 1, 10, and 100 μg/mL concentrations and each concentration was tested in four replicates. The culture plates were incubated at 37°C in a 5% CO2 humidified environment for 96 h.

The fraction of viable cells after treatment with the extracts was determined by the ability of the cells to metabolize MTT. Fifty μL of MTT (Sigma, St. Louis, MO) solution (2 mg/mL) was added to yield a final concentration of 0.4 mg/mL and the plates were further incubated at 37°C (95% air, 5% CO2) for 4 h to allow viable cells to convert soluble MTT into insoluble formazan. The medium containing MTT was aspirated and the formazan was dissolved by adding DMSO (100 μL). The absorbance of the formazan solutions was determined at 550 nm using a microplate reader (VersaMax, Molecular Devices, Inc., Sunnyvale, CA, USA). The IC50 values (concentration of drugs that will produce a 50% reduction in the absorbance compared with untreated controls) were determined from the dose-response curves (CitationStanslas et al., 2000).

In vitro test for NO inhibitory activity - Griess assay

To evaluate the inhibition of NO production by the extracts, Griess assay was employed according to the modified method of CitationDirsch et al. (1998). Briefly, RAW 264.7 cells were stimulated to produce inflammation using recombinant mouse interferon (IFN)-γ (BD Pharmingen, San Diego, CA, USA) and lipopolysaccharide (LPS) from Escherichia coli (Sigma). To evaluate the NO inhibitory activity, Griess reagent (1% sulfanilamide/0.1% N-(1-naphtyl)ethylenediamine dihydrochloride in 2.5% H3PO4) was mixed with an equal part of the cell culture medium of control or extract treated RAW 264.7 cells. The concentrations of the extract used to treat RAW 264.7 cells were 100, 10 and 1 μg/mL. The color development corresponding to NO level was assessed at 550 nm with a microplate reader (SpectraMax, Plus 384, Molecular Devices, Inc., Sunnyvale, CA, USA) and the percentage NO inhibition was determined according to the formula below. This was followed by cell viability determination using the MTT assay as described above.

Results

Yields of methanolic extract of different plant parts

The yields of the extracts obtained from different parts of Garcinia species used are shown in . The Garcinia maingayi (stem), G. forbesii King (leaf), G. nervosa (leaf) and G. griffithii (stem) produced among the highest yields with 20% and more recovery. G. urophylla (leaf),G. eugenifolia Wall (leaf), G. opaca (stem), G. opaca (leaf), G. parvifolia (leaf), G. cantleyana (leaf), G. malaccensis (leaf), G. prainiana (leaf) and G. griffithii (leaf) demonstrated percentage yields of between 10 and 20%. The rest of the extracts had yields less than 10%.

Cytotoxic activity of extracts against tumor cell lines

The 32 crude methanol extracts obtained from different parts of Garcinia species were tested for cytotoxic effect on three human tumor cell lines, representing tumors of the breast, lung and prostate. An extract was considered active if it had a mean IC50 < 100 μg/mL in any of the three cell lines. Among the active extracts, IC50 < 10 μg/mL in at least one tumor cell line was classified as strong activity, whereas extracts with IC50 in the range of 10-100 μg/mL were considered to have moderate activity. In addition, an extract was considered to have selective cytotoxic effect if it showed a pronounced difference in the activity among the three cell lines.

Based on the activity criteria set as above, the extracts were divided into 4 categories designated as A (strong and selective activity), B (strong activity without selectivity), C (moderate activity) and D (not active) (). From the results of our study, group A consisted of eight extracts and among these, G. opaca (fruit), G. urophylla (leaf), G. maingayi (stem) and G. maingayi (leaf) were selective towards MCF-7 cells with IC50 values of 8 ± 4, 3 ± 1, 6 ± 3 and 10 ± 9 μg/mL, respectively. The extract G. urophylla (leaf) showed approximately 12- and 11-fold selectivity towards MCF-7 cells as compared with DU-145 and NCI-H460 cells, respectively. Meanwhile the stem extract of G. maingayi displayed approximately 6-fold selectivity towards MCF-7 cells as compared with DU-145 and NCI-H460 cells. G. opaca fruit extract was approximately 5-fold and 4-fold selectivity towards MCF-7 cells as compared with DU-145 and NCI-H460 cells, respectively. G. maingayi leaf extract was roughly 4-fold selective in inhibiting the growth of MCF-7 cells as compared with DU-145 and NCI-H460 cells. The extracts of G. nigrolineata (stem) and G. cantleyana (leaf and stem) showed pronounced preferences in their cytotoxicity towards NCI-H460 and DU-145 in comparison to MCF-7 cells, with the activity being 3- to14-fold selective. G. penangiana (leaf) extract was selective towards MCF-7 cells and NCI-H460 cells with IC50 values of 5 ± 1 and 8 ± 2 μg/mL, respectively.

Table 3. IC50 values of Garcinia extracts in three human tumor cell lines.

The extract of G. nigrolineata (leaf) was placed in group B, which was equipotent in all cell lines. There were 18 extracts with IC50 values in the range of 10-100 μg/mL and therefore were placed into group C. Among these, the extracts of G. cowa (stem), G. bancana (stem) and G. malaccensis (leaf) were selective toward NCI-H460 as compared with MCF-7 and DU-145 cells. However, the extracts of G. bancana (leaf), G. rostrata (leaf), G. forbesii (leaf), G. opaca (stem) and G. parvifolia (leaf) were selective towards MCF-7 compared with DU-145 and NCI-H460 cells. Nine extracts were selective toward two types of tumor cell lines, of which the extracts of G. nervosa (stem and leaf), G. prainaina (leaf) and G. urophylla (stem) were selective towards DU-145 and NCI-H460 cells, while the extracts of G. forbesii (stem), G. penangiana (stem), G. griffithii (leaf and stem) and G. opaca (leaf) showed selectivity towards MCF-7 and NCI-H460 tumor cells. Only G. prainaina was equiactive in all the three tumor cell lines.

The extracts of those which did not show cytotoxicity were placed in group D (IC50 > 100 μg/mL). These include G. rostrata (stem), G. eugenifolia (leaf and stem), G. malaccensis (stem) and G. merguensis (stem).

Inhibition of LPS and IFN-g-activated NO production by RAW 264.7 cells

The 32 extracts were also tested for nitric oxide inhibitory activity in RAW 264.7 macrophage cell line. The results were divided into 4 categories: A (strong NO inhibitory activity with IC50<30 μg/mL and not cytotoxic); B (moderate NO inhibitory activity with IC50 30-100 μg/mL and not cytotoxic; C (false inhibition of NO with IC50<100 μg/mL but cytotoxic; D (not active) (). Group A consisted of seven extracts and among these, G. bancana (stem) and G. malaccensis (stem) extracts showed a strong NO inhibitory activity with IC50 2 μg/mL. In addition these extracts had the highest selectivity indices of > 50 (lowest cytotoxicity). Group B consisted of six extracts, which include the extracts from G. maingayi (leaf), G. penangiana (stem), G. bancana (leaf), G. opaca (leaf), G. eugeniifolia (leaf) and G. forbesii (stem). The extracts of G. maingayi (stem), G. urophylla (leaf), G. penangiana (leaf), G. opaca (fruits), G. parvifolia (leaf), G. nigrolienata (stem and leaf), G. cantleyana (stem and leaf) G. merguensis (stem), G. griffithii (stem and leaf),G. prainiana (stem) and G. malaccensis (leaf) belonged to group C. The extracts represented in group D consisted of G. opaca (stem), G. urophylla (stem), G. eugeniifolia (stem), G. nervosa (stem) and G. forbesii (leaf).

Table 4. *Nitric oxide inhibitory activity of plant extracts.

Discussion

A substantial number of studies on the antitumor activities of Garcinia species have been reported and their activities were often attributed to the presence of xanthones, triterpenes, depsidones and benzophenones (CitationCao et al., 1998; CitationXu et al., 1998, Citation2000; CitationMackeen et al., 2000; CitationThoison et al., 2000; CitationMatsumoto et al., 2003b). The chemopreventive effects of xanthones and benzophenones from G. assigu and G. fusca were also reported (Ito et al., Citation2003a, Citation2003b). The extracts as potential cytotoxic agents are those categorized in group A (), which include G. urophylla (leaf), G. maingayi (stem), G. maingayi (leaf), G. opaca (fruit), G. nigrolineata (stem), G. cantleyana (leaf), G. penangiana (leaf) and G. cantleyana (stem). G. urophylla (leaf), G. maingayi (stem) and G. opaca (fruit) extracts were especially interesting due to their strong and selective in vitro cytotoxic activity against the hormone-dependent breast tumor cells, MCF-7. The extract from G. cowa (stem) also showed promising results, with more than 10-fold selectivity towards the non-small lung cancer cells (NSCL) (NCI-H460) compared with MCF-7 and DU-145 cells.

This is intriguing considering the fact there are no drugs presently available to effectively treat NSCL tumors. Cytotoxic chemotherapeutic drugs currently employed in the management of NSCL cancer patients often fail because of the intrinsic resistance of the cancer cells. Based on this study, it can be concluded that these plants have cytotoxic properties, and although the plants are not usually used traditionally to treat cancer, this discovery is indeed invigorating for further studies to be undertaken on them. It is interesting to note we recently reported the isolation of potent cytotoxic xanthones from G. urophylla (CitationKhalid et al., 2007), G. penangiana (CitationJabit et al., 2007) and G. cantleyana (CitationShadid et al., 2007), which goes on to prove that the active plant extracts do contain prospective anticancer agents.

A search of the literature revealed that there have not been many studies dealing with anti-inflammatory activities of Garcinia species. Some xanthones and their derivatives, which are commonly found in Garcinia have been shown to be effective as allergy inhibitors and bronchodilators in the treatment of asthma (CitationBalasubramaniam & Rajagopalan, 1988). A study by CitationNakatani et al. (2002) showed that γ-mangostin isolated from G. mangostana inhibited cyclooxygenase and prostaglandin E2 synthesis, properties relating to anti-inflammatory effect. In the present study, the group A extracts (), especially those exhibiting high selectivity indices for inhibition of NO, such as G. bancana (stem) and G. malaccensis (stem) are expected to contain potent lead anti-inflammatory agents which could pave the way in the discovery of novel clinical candidates. A recent study reported the isolation of garcinol, isogarcinol and [1,1’-biphenyl]-2-(3-methyl-2-butenyl)-3-methoxy-4,4’,5,6-tetraol as antibacterial agents from G. bancana twigs (CitationRukachaisirikul et al., 2005) and since the plant showed NO inhibitory activity, we propose these compounds could also potentially be responsible for NO inhibition. Nevertheless, other extracts in this group should also be studied further for isolation of their phytochemicals responsible for the NO inhibitory activity. However, although some of the extracts from group C showed good inhibition of NO production, this effect is strongly believed to be due to the extracts’ cytotoxic effect on RAW 264.7 cells, thus termed as “false” potent NO inhibitory effect.

In conclusion, several Garcinia species exhibited remarkable in vitro cytotoxic and nitric oxide inhibitory activities based on this preliminary study and warrant further detailed investigation to isolate and identify the phytochemicals responsible for the biological activities. The extracts with potential selective cytotoxic agents are G. opaca (fruits), G. maingayi (stem and leaf), G. nigrolineata (stem), G. penangiana (leaf) and G. cowa (stem). For identification of prospective lead compounds for development of clinically active novel anti-inflammatory agents, extracts of G. bancana (stem) and G. malaccensis (stem) ought to be considered as the most promising extracts, as these extracts selectively inhibited NO production without killing the normal RAW 264.7 cells. Currently, studies are in progress in our laboratory to isolate the bioactive compounds from some of the Garcinia species that showed superior biological activities found in this study and the outcome will be reported elsewhere.

Acknowledgements

The authors gratefully acknowledge the Malaysian Ministry of Science, Technology and Innovation (MOSTI) for the financial support provided under the Intensification of Research in Priority Areas (IRPA) grants (09-02-04-0313, 06-02-04-0088 and 06-02-04-0603-EA001).

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

References

  • Balasubramaniam K, Rajagopalan K (1988): Novel xanthoids from Garcinia mangostana, structures of Br-xanthone-A and Br-xanthones-B. Phytochemistry 27: 1552–1554.
  • Burkill IH (1966): A Dictionary of the Economic Products of the Malay Peninsula, Vol. II. Kuala Lumpur, Art Printing Works, pp. 1063–1074.
  • Cao SG, Sng VHL, Wu HX, Sim KY, Tan BHK, Pereira JT, Goh SH (1998): Novel cytotoxic prenylated xanthoids from Garcinia gaudichaudii (Guttiferae). Tetrahedron 54: 10915–10924.
  • Chiang Y, Kuo Y, Oota S, Fukuyama Y (2003): Xanthones and benzophenones from the stems of Garcinia multiflora. J Nat Prod 66: 1070–1073.
  • Corner EJH (1988). Mangosteen family. In: Wayside Trees of Malaysia, Vol. I. Kuala Lumpur, Malayan Nature Society, pp. 349–357.
  • Dirsch VM, Stuppner H, Vollmar AM (1998): The Griess assay: Suitable for a bio-guided fractionation of anti-inflammatory plant extracts. Planta Med 64: 423–426.
  • Heras BDL, Abad MJ, Silvan AM, Pascual R, Bermejo P, Rodriguez B, Villar AM (2001): Effects of six diterpenes on macrophage eicosanoid biosynthesis. Life Sci 70: 269–278.
  • Ito C, Itoigawa M, Takakura T, Ruangrungsi N, Enjo F, Tokuda H, Nishnino H, Furukawa H (2003a ): Chemical constituents of Garcinia fusca: Structure elucidation of eight new xanthones and their chemopreventive activity. J Nat Prod 66: 200–205.
  • Ito C, Itoigawa M, Miyamoto Y, Onoda S, Rao KS, Mukainaka T, Tokuda H, Nishino H, Furukawa H (2003b ): Polyprenylated benzophenones from Garcinia assigu and their potential chemopreventive activities. J Nat Prod 66: 206–209.
  • Jabit ML, Khalid R, Abas F, Shaari K, Hui LS, Stanslas J, Lajis NH (2007): Cytotoxic xanthones from Garcinia penangiana Pierre. Z. Naturforsch 62c: 786-792.
  • Kenji M, Yukihiro A, Emi K, Tetsuro I, Kenji O, Toshiyuki T, Munekazu I, Yoshinori N (2003): Cytotoxic benzophenone derivatives from Garcinia species display a strong apoptosis-inducing effect against human leukemia cell lines. Biol Pharm Bull 26: 569–571.
  • Khalid RM, Jabit ML, Abas F, Stanslas J, Shaari K, Lajis NH (2007): Cytotoxic xanthones from the leaves of Garcinia urophylla. Nat Prod Commun 2: 271–276.
  • Likhitwitayawuid K, Phadungcharoen T, Krungkrai J (1998): Antimalarial xanthones from Garcinia cowa. Planta Med 64: 70–72.
  • Lin YM, Anderson H, Flavin MT, Pai YHS, Mata-Greenwood E, Pengsuparp T, Pezzuto JM, Schinazi RF, Hughes SH, Chen FC (1997): In vitro anti-HIV activity of biflavanoids isolated from Rhus succedanea and Garcinia multiflora. J Nat Prod 60: 884–888.
  • Mackeen MM, Ali AM, Lajis NH, Kawazu K, Hassan Z, Amran M, Habsah M, Mooi LY and Mohamad SM (2008): Antimicrobial, antioxidant, antitumour-promoting and cytotoxic activities of different plant part extracts of Garcinia atroviridis Griff. ex T. Anders. J Ethnopharmacol 72(200): 395–402.
  • Matsumoto K, Akao YY, Kobayashi E, Ito T, Ohguchi K, Tanaka T, Iinuma M, Nozawa Y (2003a): Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines. J Nat Prod 66: 1124–1127.
  • Matsumoto K, Akao Y, Kobayashi E, Ito T, Ohguchi K, Tanaka T, Iinuma M, Nozawa Y (2003b): Cytotoxic benzophenone derivatives from Garcinia species display a strong apoptosis-inducing effect against human leukemia cell lines. Biol Pharm Bull 26: 569–571.
  • Nakatani K, Nakahata N, Arakawa T, Yasuda H, Ohizumi Y (2002): Inhibition of cyclooxygenase and prostaglandin E2 synthesis by γ-mangostin, a xanthone derivative in mangosteen, in C6 rat glioma cells. Biochem Pharmacol 63: 73–79.
  • Na Pattalung P, Thongtheeraparp W, Wiriyachitra P, Taylor WC (1994): Xanthones of Garcinia cowa. Planta Med 60: 365–368.
  • Peres V, Nagem TJ, Fernando O (2000): Tetraoxygenated naturally occurring xanthones. Phytochemistry 55: 683–710.
  • Permana D, Lajis NH, Mackeen MM, Ali AM, Aimi N, Kitajima M, Takayama H (2001): Isolation and bioactivities of constituents of the roots of Garcinia atroviridis. J Nat Prod 64: 976–979.
  • Rukachaisirikul V, Kamkaew M, Sukavisit D, Phongpaichit S, Sawangchote P, Taylor WC (2003): Antibacterial xanthones from the leaves of Garcinia nigrolineata. J Nat Prod 66: 1531–1535.
  • Rukachaisirikul V, Naklue W, Sukpondma Y, Phongpaichit S (2005): An antibacterial biphenyl derivative from Garcinia bancana MIQ. Chem Pharm Bull 53: 342–343.
  • Rukachaisirikul V, Trisuwan K, Sukpondma Y, Phongpaichit S (2008): A new benzoquinone derivative from the leaves of Garcinia parvifolia. Arch Pharm Res 31: 17–20.
  • Sadaquat A, Renee G, Subramaniam S, Bleaulieu C, Spino C (2000): Benzophenones of Garcinia pseudoguttifera (Clusiaceae). Phytochemistry 53: 281–284.
  • Shadid KA, Shaari K, Abas F, Israf DA, Hamzah AS, Syakroni N, Saha K, Lajis NH (2007): Cytotoxic caged-polyprenylated xanthonoids and a xanthone from Garcinia cantleyana. Phytochemistry 68: 2537–2544.
  • Stanslas J, Hagan DJ, Ellis MJ, Turner C, Carmicheal J, Ward W, Hammonds TR, Stevens MFG (2000): Antitumor polycyclic acridine. 7. Synthesis and biological properties of DNA affinic tetra- and pentacyclic acridine. J Med Chem 43: 1563–1572.
  • Thoison O, Fahy J, Dumontet V, Chiaroni A, Riche C, Tri MV, Sevenet T (2000): Cytotoxic prenylxanthones from Garcinia bracteata. J Nat Prod 63: 441–446.
  • Waterman PG, Hussain RA (1983): Systematic significance of xanthones, benzophenones and biflavonoids in Garcinia. Biochem Syst Ecol 11: 21–28.
  • Xu YJ, Cao SG, Wu XH, Lai YH, Tan BHK, Pereira JD, Goh SH, Venkatraman G, Harrison LJ, Sim KY (1998): Griffipavixanthone, a novel cytotoxic bixanthone from Garcinia griffithi and Garcinia parvifolia. Tetrahedron Lett 39: 9103–9106.
  • Xu YJ, Chiang P, Lai YH, Vittal JJ, Wu XH, Tan BKH, Imiyabir Z, Goh S (2000): Cytotoxic prenylated depsidones from Garcinia parvifolia. J Nat Prod 63: 1361–1363.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.